# Jerome Van Biervliet

> Jerome Van Biervliet is a Series A investor at VIB (Tielt) backing Health Care and Life Science. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [VIB](https://shizune.co/investors/profile/vib)
- Location: Tielt, Belgium
- Total investments: 1
- Last investment: Jul 2020
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/jerome-van-biervliet-6049279
- X (Twitter): https://twitter.com/JVanbiervliet
- Website: https://x.com/JVanbiervliet

Jerome Van Biervliet is a Series A investor at VIB in Tielt focused on Health Care and Life Science. Jerome Van Biervliet is the Managing Director of VIB.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Life Science | 1 | 100% |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| ExeVir Bio | ExeVir Bio is a Belgium-based company that develops single-domain antibody-based therapies that help patients ward off viral infections. The company is harnessing a llama-derived antibody technology platform to generate robust antiviral therapies providing broad protection against coronaviruses. They using a highly innovative and clinicallyvalidated VHH technology to develop treatments for viral infections that may pose a significant global threat. ExeVir Bio develops a rapid response platform for antivirals. This platform technology enables an agile response to new health threats thanks to its short throughput time to generate drug candidates. The resulting protein-based therapeutics are sufficiently stable and easy to produce at a reasonable cost to enable true global access.ExeVir Bio was founded in 2020 and is headquartered in Zwijnaarde, Belgium. | $49.2M | Series A | Jul 28, 2020 |  |

1 of 1 investments shown.

## Co-investors
- [UCB Ventures](https://shizune.co/investors/profile/ucb-ventures) — VC Fund, 2 deals together
- [Fund+](https://shizune.co/investors/profile/fund) — VC Fund, 1 deal together
- [Meusinvest (Noshaq)](https://shizune.co/investors/profile/meusinvest) — VC Fund, 1 deal together
- [Sambrinvest](https://shizune.co/investors/profile/sambr-invest) — VC Fund, 1 deal together
- [SFPI-FPIM](https://shizune.co/investors/profile/sfpi-fpim) — VC Fund, 1 deal together
- [S.R.I.W.](https://shizune.co/investors/profile/s-r-i-w) — VC Fund, 1 deal together

## About VIB

VC Fund · Gent, Belgium

VIB, a Belgium-based life sciences research institute, performs research for pharmaceutical, agricultural, and industrial applications.

5 contacts available at VIB.

| Name | Title | Profile |
| --- | --- | --- |
| Erwin Sablon | Expert Scientist Diagnostics & Biomarkers | https://shizune.co/investors/profile/erwin-sablon |
| Isabel Vercauteren | Entrepreneur in Residence | https://shizune.co/investors/profile/isabel-vercauteren |
| Jan Steyaert | Groupleader; Director | https://shizune.co/investors/profile/jan-steyaert |
| Jerome Van Biervliet | Managing Director | https://shizune.co/investors/profile/jerome-van-biervliet |
| Jo Bury | Managing Director | https://shizune.co/investors/profile/jo-bury |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Jerome Van Biervliet invest in?

Jerome Van Biervliet invests primarily in Health Care, Life Science and Therapeutics startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Jerome Van Biervliet last invest?

The most recent investment recorded for Jerome Van Biervliet closed in Jul 2020. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co